Contrary to the assumption that hyperactivating mutations in GC-C might play a protective role in tumourigenesis, we speculate that a prolonged increase in intestinal epithelial cGMP levels, leading to a greater predisposition towards IBD [118,142], might result in an increased incidence of inflammation-associated colorectal cancer (CRC). Here, GUCY2C is linked to inflammatory bowel disease.